Challenges for the translation of T cell costimulatory blockade therapies to the clinic

Bibliography

• LAFFERTY KJ, CUNNINGHAM AJ: Anew analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sri. (1975) 53:27–42.
   PubMedGoogle Scholar
• LECHLER R, CHAT JG, MARELLI-BERG F, LOMBARDI G: T-cell anergy and peripheral T-cell tolerance. Philos. Trans. R. Soc. Lond. B. Biol. Sci. (2001) 356:625–637.
   PubMed Web of Science ®Google Scholar
• BLUESTONE JA: New perspectives of CD28-B7-mediated T cell costimulation. Immunity (1995) 2:555–559.
   PubMed Web of Science ®Google Scholar
• WATTS TH, De BENEDETTE MA: T cell co-stimulatory molecules other than CD28. Curt: Opin. Inonunol. (1999) 11:286–293.
   Google Scholar
• SAYEGH MH, TURKA LA: The role of T-cell costimulatory activation pathways in transplant rejection. N. Engl I Med. (1998) 338:1813–1821.
   PubMed Web of Science ®Google Scholar
• YAMADA A, SALAMA AD, SAYEGH MH: The role of novel T cell costimulatory pathways in autoimmunity and transplantation." Jim. Soc. Neplirol. (2002) 13:559–575.
   PubMed Web of Science ®Google Scholar
• •A comprehensive review of the role of costimulatory molecules in transplantation and autoimmunity.
   Google Scholar
• LIANG B, GEE RJ, KASHGARIAN MJ, SHARPE AH, MAMULA MJ: B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-B7.1/B7.2 blocking antibodies. binnunol. (1999) 163:2322–2329.
   Google Scholar
• REYNOLDS J, TAM FW, CHANDRAKER A et al: CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. Clin. Invest. (2000) 105:643–651.
   Google Scholar
• KUCHROO VK, DAS MP, BROWN JA et al.: B7-1 and B7-2 costimulatory molecules activate differentially the Thl/ Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 80:707–718.
   PubMed Web of Science ®Google Scholar
• GALLON L, CHANDRAKER A, ISSAZADEH S et al.: Differential effects of B7-1 blockade in the rat experimental autoimmune encephalomyelitis model. " konunol. (1997) 159:4212–4216.
   Google Scholar
• LENSCHOW DJ, HO SC, SATTAR H et al.: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. Exp. Med. (1995) 181:1145–1155.
   PubMed Web of Science ®Google Scholar
• SHI FD, HE B, LI H, MATUSEVICIUS D, LINK H, LJUNGGREN HG: Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis. Eur: konunol. (1998) 28:3587–3593.
   Web of Science ®Google Scholar
• TADA Y, NAGASAWA K, HO A et al.: CD28-deficient mice are highly resistant to collagen-induced arthritis. I binnunol. (1999) 162:203–208.
   Google Scholar
• SHAO H, WOON MD, NAKAMURA S et al.: Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. nvest. Ophthalmol. Vis. Sci. (2001) 42:2016–2021.
   PubMed Web of Science ®Google Scholar
• DAIKH DI, FINCK BK, LINSLEY PS, HOLLENBAUGH D, WOFSY D: Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. ImmunoL (1997) 159:3104–3108.
   Web of Science ®Google Scholar
• KOVER KL, GENG Z, HESS DM, BENJAMIN CD, MOORE WV: Anti-CD154 (CD4OL) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes (2000) 49: 1666-1670.
   Google Scholar
• MOLANO RD, BERNEY T, LI H et al.:Prolonged islet graft survival in NOD mice by blockade of the CD4O-CD154 pathway of T-cell costimulation. Diabetes (2001) 50:270–276.
   PubMed Web of Science ®Google Scholar
• BECHER B, DURELL BG, MIGA AV, HICKEY WF, NOELLE RJ: The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. Exp. Med. (2001) 193:967–974.
   PubMed Web of Science ®Google Scholar
• TURKA LA, LINSLEY PS, LIN H et al.:T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA (1992) 89:11102–11105.
   PubMed Web of Science ®Google Scholar
• LIN H, BOLLING SF, LINSLEY PS et al.:Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. Exp. Med. (1993) 178:1801–1806.
   PubMed Web of Science ®Google Scholar
• PEARSON TC, ALEXANDER DZ, WINN KJ, LINSLEY PS, LOWRY RP, LARSEN CP: Transplantation tolerance induced by CTLA4-Ig. Transplantation (1994) 57: 1701-1706.
   Google Scholar
• SAYEGH MH, AKALIN E, HANCOCK WW et al.: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Thl cytokines but spares Th2. I. Exp. Med. (1995) 181:1869–1874.
   PubMed Web of Science ®Google Scholar
• YAMADA A, KISHIMOTO K, DONG VM et al.: CD28 independent costimulation of T cells in alloimmune responses. ImmunoL (2001) 167:140–146.
   Web of Science ®Google Scholar
• KIM KS, DENTON MD, CHANDRAKER A et al.: CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis. Am. J. PathoL (2001) 158:977–986.
   PubMed Web of Science ®Google Scholar
• FURUKAWA Y, MANDELBROT DA, LIBBY P, SHARPE AH, MITCHELL RN: Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. Am. J. PathoL (2000) 157:473–484.
   Google Scholar
• LARSEN CP, ALEXANDER DZ, HOLLENBAUGH D et al.: CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation (1996) 61:4–9.
   Google Scholar
• PARKER DC, GREINER DL, PHILLIPS NE et al.: Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. NatL Acad. Sci. USA (1995) 92:9560–9564.
   PubMed Web of Science ®Google Scholar
• HANCOCK WW, SAYEGH MH, ZHENG XG, PEACH R, LINSLEY PS, TURKA LA: Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. ScL USA (1996) 93:13967–13972.
   PubMed Web of Science ®Google Scholar
• ENSMINGER SM, WITZKE 0, SPRIEWALD BM et al.: CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation (2000) 69:2609–2612.
   Google Scholar
• •Investigates some of the costimulatory resistant pathways in transplantation.
   Google Scholar
• SHIMIZU K, SCHONBECK U, MACH F, LIBBY P, MITCHELL RN: Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. ImmunoL (2000) 165:3506–3518.
   Web of Science ®Google Scholar
• LARSEN CP, ELWOOD ET, ALEXANDER DZ et al.: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature (1996) 381:434–438.
   PubMed Web of Science ®Google Scholar
• KIRK AD, HARLAN DM, ARMSTRONG NN et al.: CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. NatL Acad. Sci. USA (1997) 94:8789–8794.
   PubMed Web of Science ®Google Scholar
• LEVISETTI MG, PADRID PA, SZOT GL et al.: Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. ImmunoL (1997) 159:5187–5191.
   Web of Science ®Google Scholar
• KIRK AD, BURKLY LC, BATTY DS et al.: Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. (1999) 5:686–693.
   PubMed Web of Science ®Google Scholar
• KENYON NS, CHATZIPETROU M, MASETTI M et al.: Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc. NatL Acad. Sci. USA (1999) 96:8132–8137.
   PubMed Web of Science ®Google Scholar
• ABRAMS JR, LEBWOHL MG, GUZZO CA et al.: CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.Clin. Invest. (1999)103:1243–1252.
   Google Scholar
• ••The only published trial of costimulatoryblockade in human autoirnmune disease.
   Google Scholar
• GUINAN EC, BOUSSIOTIS VA, NEUBERG D et al.: Transplantation of anergic histoincompatible bone marrow allografts. N EngL J. Med. (1999) 340:1704–1714.
   PubMed Web of Science ®Google Scholar
• ••A trial using costimulatory blockade toinduce anergy in bone marrow transplantation.
   Google Scholar
• KAWAI T, ANDREWS D, COLVIN RB, SACHS DH, COSIMI AB: Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat. Med. (2000) 6:114.
   Web of Science ®Google Scholar
• YAMADA, SAYEGH MH: The CD154-CD40 costimulatory pathway in transplantation. Transplantation (2002) 73 (Suppl. 1):S36–S39.
   Google Scholar
• •Reviews the current knowledge regarding the CD4O-CD154 pathway and its prospects in transplantation.
   Google Scholar
• LI Y, LI XC, ZHENG XX, WELLS AD,TURKA LA, STROM TB: Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med. (1999) 5:1298–1302.
   PubMed Web of Science ®Google Scholar
• LI XC, STROM TB, TURKA LA, WELLS AD: T cell death and transplantation tolerance. Immunity (2001) 14:407–416.
   PubMed Web of Science ®Google Scholar
• •An excellent essay on the role of T cell deletion in tolerance induction.
   Google Scholar
• KAWAI T, COSIMI AB, COLVIN RB et al.: Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 59:256–262.
   PubMed Web of Science ®Google Scholar
• SHO M, SANDNER SE, NAJAFIAN N et al.: New insights into the interactionbetween costimulation blockade and conventional immunosuppressive drugs. Ann. Sing. (2002). In press.
   Google Scholar
• ROTTMAN JB, SMITH T, TONRA JR et al.: The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Inanuna (2001) 2:605–611.
   Google Scholar
• •The role of the novel ICOS pathway in autoirnmune EAE.
   Google Scholar
• OZKAYNAK E, GAO W, SHEMMERI N et al: Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat. Innnunol. (2001) 2:591–596.
   PubMed Web of Science ®Google Scholar